Miracle drug innovations — such as those that sparked the meteoric rise of Wegovy and Zepbound — could come every couple of ...

Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...

Several foreign drugmakers have announced debuts for their new drugs in the Chinese market since the beginning of 2025, as ...

but the industry is already seeing payers responding with more aggressive price negotiations and more selective reimbursement of new drug launches. Some NME approvals are now taking longer than ...

Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, ...

Discover why Incyte's strong growth trajectory and upcoming product launches make it an attractive investment with a $94/share price target. Read more here.

“The availability of Full-Length DRUG-seq is the latest in a series of new technology launches that we will continue through 2025. These new products and services will continue to leverage ...

Merck & Co. expects to launch an easier-to-administer version of its blockbuster cancer treatment Keytruda before the end of ...

Miracle drug innovations — such as those that sparked the meteoric rise of Wegovy and Zepbound — could come every couple of years thanks to new technologies, former U.S. Treasury Secretary ...

The development of new drugs is critical in treating cancer—if people have access to them. A team co-led by Penn State ...